Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.505
-0.122 (-19.44%)
At close: Nov 4, 2024, 4:00 PM
0.510
+0.005 (1.01%)
After-hours: Nov 4, 2024, 7:59 PM EST

Cyclacel Pharmaceuticals Stock Forecast

CYCC's stock price has decreased by -94.21% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for CYCC stock has a target of 11, which predicts an increase of 2,078.22% from the current stock price of 0.51.

Analyst Consensus: Buy
Target Low Average Median High
Price $11 $11 $11 $11
Change +2078.2% +2078.2% +2078.2% +2078.2%
* Price targets were last updated on May 3, 2024.

Analyst Ratings

The average analyst rating for CYCC stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 111111
Buy 111110
Hold 111111
Sell 000000
Strong Sell 000000
Total 333332

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Roth MKM
Roth MKM
Strong Buy
Maintains
$21$11
Strong Buy Maintains $21$11 +2,078.22% May 3, 2024
Brookline Capital
Brookline Capital
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Maintains
$16$21
Strong Buy Maintains $16$21 +4,058.42% Dec 19, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$120
Buy Maintains $120 +23,662.38% May 25, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$150$120
Buy Maintains $150$120 +23,662.38% Mar 7, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
43.86K
from 420.00K
Decreased by -89.56%
Revenue Next Year
51.00K
from 43.86K
Increased by 16.28%
EPS This Year
-3.19
from -26.75
EPS Next Year
-2.03
from -3.19
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
----420.00K43.86K51.00K102.00K
Revenue Growth
------89.56%16.28%100.00%
EPS
-147.62-51.30-31.35-28.52-26.75-3.19-2.03-1.62
EPS Growth
--------
Forward PE
--------
No. Analysts -----443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 55,650 105,000 105,000
Avg 43,860 51,000 102,000
Low 32,340 n/a 98,000

Revenue Growth

Revenue Growth 20242025202620272028
High
-86.8%
139.4%
105.9%
Avg
-89.6%
16.3%
100.0%
Low
-92.3%
-
92.2%

EPS Forecast

EPS 20242025202620272028
High -2.40 -1.64 -1.67
Avg -3.19 -2.03 -1.62
Low -3.89 -2.37 -1.56

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.